Orally active peptide antagonizes KOR in CNS

E-ISSN： 1476-5381|169|2|426-436

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.169, Iss.2, 2013-05, pp. : 426-436

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ST1926, an orally active synthetic retinoid, induces apoptosis in chronic myeloid leukemia cells and prolongs survival in a murine model

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 3, 2015-08 ,pp. : 698-709

John Wiley & Sons Inc

Access to resources Recommend Favorite

The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophy

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 10, 2015-05 ,pp. : 2618-2633

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enantioselective pharmacodynamic and pharmacokinetic analysis of two chiral CNS‐active carbamate derivatives of valproic acid

EPILEPSIA, Vol. 55, Iss. 12, 2014-12 ,pp. : 1944-1952

John Wiley & Sons Inc

Access to resources Recommend Favorite

Unravelling the T‐cell‐mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34–56 peptide in incomplete adjuvant

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 42, Iss. 1, 2012-01 ,pp. : 217-227

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bradykinin Antagonizes the Effects of α-Thrombin

By Ehringer William D. Edwards Michael J. Gray Robert D. Miller Frederick N.

Inflammation, Vol. 21, Iss. 3, 1997-06 ,pp. : 279-298

Springer Publishing Company

Access to resources Recommend Favorite